Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: David Graham who wrote (742)	2/25/1998 6:36:00 PM
From: Biomaven	Respond to of 1826

Grammy, Thanks. No need to dig out the actual purchase date - just wanted to make sure they're not being careless. It's actually kind of hard for someone like Blitzer to _ever_ make an open market purchase in a company like this. The point is that he's pretty much always in possession of material non-public information (like the exact status of the trials and the European negotiations for MGI-114). Paradoxically, a purchase by Blitzer in the open market would actually be a signal that there were no luscious (or, for that matter, disastrous)pending announcements coming any time soon. A few days after the release of a 10-k is the safest time for real insiders to trade. Peter